What is Section 280E of the Internal Revenue Code and how does it affect cannabis businesses?

Section 280E prohibits deductions for businesses trafficking in Schedule I or II controlled substances. Cannabis businesses can deduct cost of goods sold but cannot deduct other ordinary business expenses (wages, rent, utilities, marketing). This creates effective federal tax rates of 50-80% for cannabis operators — dramatically higher than equivalent businesses in other industries.

Will federal rescheduling to Schedule III automatically eliminate 280E?

Rescheduling to Schedule III would remove cannabis from the Schedule I and II categories that trigger 280E, likely eliminating 280E's application to cannabis businesses. However, the IRS and tax practitioners have noted that the statutory language of 280E references Section I and II specifically — rescheduling to III would logically remove cannabis from 280E's scope, but IRS guidance and potentially Congressional action to confirm this outcome would be important.

Can cannabis businesses deduct expenses now, before rescheduling?

Cannabis businesses can deduct cost of goods sold (COGS) under 280E — the cost of purchasing or producing the cannabis products they sell. However, they cannot deduct other business expenses: wages, rent, insurance, legal fees, marketing. Sophisticated accounting strategies can maximize the COGS deduction, but the 280E burden remains substantial regardless.

What is the status of federal cannabis rescheduling as of 2026?

The DEA published a proposed rule to reschedule cannabis from Schedule I to Schedule III in 2024. The rulemaking process — including public comment periods and administrative review — was ongoing as of early 2026. Rescheduling to Schedule III does not legalize cannabis; it changes its regulatory and tax classification within the federal controlled substances framework.

Regulatory RegimevsRegulatory Regime

Federal Cannabis Rescheduling vs State-Level Rescheduling

Side-by-side analysis of Federal Cannabis Rescheduling and State-Level Rescheduling for cannabis business strategy, with a decisive recommendation from Hoban Law Group.

Robert Hoban

Principal & Managing Attorney, Hoban Law Group

Colorado Bar

Full profile →

Side-by-Side Comparison

Factor	Federal Cannabis Rescheduling	State-Level Rescheduling	Verdict
280E impact	Eliminates 280E — Schedule III tax treatment would not trigger Section 280E	No 280E impact — state-level action does not affect federal tax law	Federal Cannabis Rescheduling wins Federal rescheduling to Schedule III would remove the 280E tax burden — the single most impactful legal change available to licensed cannabis operators' P&L.
Banking access	Potentially enables full banking — FinCEN guidance would change	No direct banking impact — federal BSA requirements unchanged	Federal Cannabis Rescheduling wins Federal rescheduling could prompt federal banking regulators to update guidance allowing mainstream banks to serve cannabis businesses without enhanced due diligence requirements.
Interstate commerce	Does not directly enable interstate commerce — CSA scheduling reform needed	State interstate compacts can enable commerce between consenting states	State-Level Rescheduling wins Federal rescheduling alone does not enable interstate cannabis commerce. Only federal descheduling or Congressional action would permit interstate commerce. State compacts are the near-term available mechanism.
State law effect	Does not preempt state cannabis laws — states retain authority to regulate	Affects only state classification — does not change federal law	Neutral Both types of rescheduling operate in their respective spheres. Federal rescheduling changes the federal enforcement and tax landscape; state rescheduling changes state regulatory classification.
Timeline	Federal administrative process — DEA scheduling review underway	State legislative action — can occur faster than federal process	State-Level Rescheduling wins State-level rescheduling can occur through legislative action or state administrative process significantly faster than the federal DEA scheduling review process.
Industry impact magnitude	Transformative — 280E elimination alone represents billions in industry savings	Modest — state-level classification changes have limited practical effect	Federal Cannabis Rescheduling wins Federal rescheduling, particularly if accompanied by 280E elimination, would be the most impactful regulatory development in US cannabis history. State rescheduling affects state-level enforcement primarily.

Federal Cannabis Rescheduling vs State-Level Rescheduling: Impact Analysis

Federal and state cannabis rescheduling are fundamentally different regulatory actions with dramatically different consequences for licensed cannabis operators. Understanding the distinction is essential for operators who are planning business strategy around potential regulatory reform.

What Is Federal Cannabis Rescheduling?

Federal cannabis rescheduling refers to action by the Drug Enforcement Administration (DEA) to move cannabis from Schedule I (high abuse potential, no accepted medical use) to a lower schedule of the Controlled Substances Act. The Biden administration's directive to HHS and DEA to review cannabis scheduling culminated in a proposed rule to move cannabis to Schedule III.

The most consequential effect of rescheduling to Schedule III would be elimination of Section 280E of the Internal Revenue Code. Section 280E prohibits businesses trafficking in Schedule I or II substances from deducting ordinary business expenses. Cannabis businesses — which can deduct cost of goods sold but not other business expenses — face effective federal tax rates of 70%+ in many cases because of 280E. Rescheduling to Schedule III would remove this burden, potentially adding 20-40 percentage points to the effective margin of licensed cannabis operators.

What Is State-Level Cannabis Rescheduling?

Some states have moved cannabis from their state-controlled substances classifications to lower schedules or to regulatory frameworks outside their state controlled substances acts. State-level rescheduling has significant effects on state enforcement and state law, but does not affect federal law — including 280E, federal banking regulations, or federal interstate commerce restrictions.

The 280E Impact: The Core Federal Advantage

For licensed cannabis operators, the 280E question is the most important single element of the federal rescheduling analysis. The ability to deduct ordinary business expenses — rent, wages, utilities, marketing, professional services — that every other US business takes for granted would transform cannabis operator economics. Analysts estimate that 280E elimination alone would add $4-6B annually to US cannabis industry profitability at current market scale.

Decision framework

Which fits your business?

What does this mean for your business? If you are currently planning a cannabis business, you should model both the current 280E environment and a post-rescheduling environment in your financial projections. Federal rescheduling to Schedule III is not guaranteed, but the probability has increased significantly since the HHS recommendation. State-level rescheduling, while politically meaningful, does not change your federal tax burden — only federal action does. For existing cannabis operators, 280E is the most consequential tax issue in your P&L; Hoban Law Group's tax and regulatory counsel can advise on defensive tax positions and rescheduling contingency planning. [Schedule a consultation](/consultation?source=compare&compare=federal-cannabis-rescheduling-vs-state-rescheduling&matter_type=regulatory-compliance).

Federal Cannabis Rescheduling counsel →State-Level Rescheduling counsel →

Frequently Asked Questions

What is Section 280E of the Internal Revenue Code and how does it affect cannabis businesses?: Section 280E prohibits deductions for businesses trafficking in Schedule I or II controlled substances. Cannabis businesses can deduct cost of goods sold but cannot deduct other ordinary business expenses (wages, rent, utilities, marketing). This creates effective federal tax rates of 50-80% for cannabis operators — dramatically higher than equivalent businesses in other industries.
Will federal rescheduling to Schedule III automatically eliminate 280E?: Rescheduling to Schedule III would remove cannabis from the Schedule I and II categories that trigger 280E, likely eliminating 280E's application to cannabis businesses. However, the IRS and tax practitioners have noted that the statutory language of 280E references Section I and II specifically — rescheduling to III would logically remove cannabis from 280E's scope, but IRS guidance and potentially Congressional action to confirm this outcome would be important.
Can cannabis businesses deduct expenses now, before rescheduling?: Cannabis businesses can deduct cost of goods sold (COGS) under 280E — the cost of purchasing or producing the cannabis products they sell. However, they cannot deduct other business expenses: wages, rent, insurance, legal fees, marketing. Sophisticated accounting strategies can maximize the COGS deduction, but the 280E burden remains substantial regardless.
What is the status of federal cannabis rescheduling as of 2026?: The DEA published a proposed rule to reschedule cannabis from Schedule I to Schedule III in 2024. The rulemaking process — including public comment periods and administrative review — was ongoing as of early 2026. Rescheduling to Schedule III does not legalize cannabis; it changes its regulatory and tax classification within the federal controlled substances framework.

Work with Hoban Law Group

Get counsel on your Federal Cannabis Rescheduling or State-Level Rescheduling matter

Our team prepares a regulatory briefing specific to your matter before you speak with counsel. No cost. No commitment.

Schedule a consultation